241 results
8-K
EX-99.1
ALKS
Alkermes plc
24 Jul 24
Alkermes plc Reports Second Quarter 2024 Financial Results
7:05am
Litigation Reform Act of 1995, as amended, including, but not limited to, statements concerning: the company’s expectations concerning its future financial … include, among others: whether the company is able to sustain profitability; the unfavorable outcome of arbitration or litigation, including so-called
8-K
EX-99.2
ALKS
Alkermes plc
24 Jul 24
Alkermes plc Reports Second Quarter 2024 Financial Results
7:05am
Certain statements set forth in this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform … , assumptions and uncertainties include, among others: whether the Company is able to sustain profitability; the unfavorable outcome of arbitration or litigation
8-K
EX-99.1
ALKS
Alkermes plc
1 May 24
Alkermes plc Reports First Quarter 2024 Financial Results
7:05am
Litigation Reform Act of 1995, as amended, including, but not limited to, statements concerning: the company’s expectations concerning its future … , among others: whether the company is able to sustain profitability; the unfavorable outcome of arbitration or litigation, including so-called “Paragraph
8-K
EX-99.2
d5vtoonp
1 May 24
Alkermes plc Reports First Quarter 2024 Financial Results
7:05am
8-K
EX-99.1
3meef8lcwvb
9 Apr 24
Regulation FD Disclosure
7:09am
8-K
EX-99.1
5oaqsg8ty
7 Mar 24
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
7:09am
8-K
EX-99.1
jyiyfmn
15 Feb 24
Results of Operations and Financial Condition
7:05am
8-K
EX-99.2
86d7z
15 Feb 24
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
ynawhohe6zoxa 789r4
8 Jan 24
Regulation FD Disclosure
7:00am
8-K
EX-99.1
tdw4pjzqa l4t44
14 Dec 23
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk
6:13am
8-K
EX-99.2
uh8hw
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
8-K
EX-10.1
4t3l8t ts2a19pvz8gg
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
8-K
EX-10.2
whuyj54fhku0lz 1w6u
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am